NANOVIRICIDES, INC.: 10-Q filed 2012-11-19
What NANOVIRICIDES, INC. reported in its quarterly report filed 2012-11-19 (fiscal Q1 2013): 25 published measures, 72 facts as tagged in accession 0001144204-12-063924.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2012-11-19
- Fiscal period
- fiscal Q1 2013
- Accession
- 0001144204-12-063924 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All NANOVIRICIDES, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-09-30 | 14,353,743 | USD | |
| At 2012-06-30 | 15,629,808 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-09-30 | 12,796,577 | USD | |
| At 2012-06-30 | 13,850,193 | USD | |
| At 2011-06-30 | 10,170,891 | USD | |
| At 2010-06-30 | 6,518,704 | USD | |
| At 2009-06-30 | 2,485,542 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-09-30 | 12,929,665 | USD | |
| At 2012-06-30 | 14,274,985 | USD | |
| At 2011-09-30 | 10,879,319 | USD | |
| At 2011-06-30 | 9,224,023 | USD | |
| At 2005-05-11 | 0 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-07-01 to 2012-09-30 | -1,803,955 | USD | 92 |
| 2005-05-12 to 2012-09-30 | -31,228,071 | USD | 2699 |
| 2011-07-01 to 2012-06-30 | -6,207,207 | USD | 366 |
| 2011-07-01 to 2011-09-30 | -1,139,976 | USD | 92 |
| 2010-07-01 to 2011-06-30 | -6,477,165 | USD | 365 |
| 2009-07-01 to 2010-06-30 | -4,744,208 | USD | 365 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-07-01 to 2012-09-30 | -1,345,320 | USD | 92 |
| 2005-05-12 to 2012-09-30 | -21,507,521 | USD | 2699 |
| 2011-07-01 to 2011-09-30 | -676,273 | USD | 92 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-07-01 to 2012-09-30 | 0 | USD | 92 |
| 2005-05-12 to 2012-09-30 | 1,440,717 | USD | 2699 |
| 2011-07-01 to 2011-09-30 | 23,352 | USD | 92 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-07-01 to 2012-09-30 | 0 | USD | 92 |
| 2005-05-12 to 2012-09-30 | 36,336,858 | USD | 2699 |
| 2011-07-01 to 2011-09-30 | 2,360,654 | USD | 92 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-07-01 to 2012-09-30 | 0 | USD | 92 |
| 2005-05-12 to 2012-09-30 | -1,899,672 | USD | 2699 |
| 2011-07-01 to 2011-09-30 | -29,085 | USD | 92 |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-07-01 to 2012-09-30 | 0 | USD | 92 |
| 2005-05-12 to 2012-09-30 | 0 | USD | 2699 |
| 2011-07-01 to 2011-09-30 | 0 | USD | 92 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-09-30 | 562,123 | USD | |
| At 2012-06-30 | 614,842 | USD |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-07-01 to 2012-09-30 | -1,590,985 | USD | 92 |
| 2005-05-12 to 2012-09-30 | -30,398,672 | USD | 2699 |
| 2011-07-01 to 2011-09-30 | -1,140,428 | USD | 92 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-09-30 | 13,368,006 | USD | |
| At 2012-06-30 | 14,589,159 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-09-30 | 1,557,166 | USD | |
| At 2012-06-30 | 1,779,615 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-07-01 to 2012-09-30 | 1,590,985 | USD | 92 |
| 2005-05-12 to 2012-09-30 | 30,398,672 | USD | 2699 |
| 2011-07-01 to 2011-09-30 | 1,140,428 | USD | 92 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-07-01 to 2012-09-30 | 1,209,818 | USD | 92 |
| 2005-05-12 to 2012-09-30 | 19,720,969 | USD | 2699 |
| 2011-07-01 to 2011-09-30 | 691,699 | USD | 92 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-09-30 | 158,391,799 | shares | |
| At 2012-06-30 | 155,612,293 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-09-30 | 43,856,353 | USD | |
| At 2012-06-30 | 43,108,790 | USD |
Gross property, plant and equipment
Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-09-30 | 1,440,717 | USD | |
| At 2012-06-30 | 1,440,717 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-09-30 | 878,594 | USD | |
| At 2012-06-30 | 825,875 | USD |
Net intangible assets excluding goodwill
Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-09-30 | 423,614 | USD | |
| At 2012-06-30 | 425,807 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-09-30 | 98,258 | USD | |
| At 2012-06-30 | 96,878 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-07-01 to 2012-09-30 | -1,803,955 | USD | 92 |
| 2005-05-12 to 2012-09-30 | -31,228,071 | USD | 2699 |
| 2011-07-01 to 2011-09-30 | -1,139,976 | USD | 92 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-07-01 to 2012-09-30 | 381,167 | USD | 92 |
| 2005-05-12 to 2012-09-30 | 11,098,545 | USD | 2699 |
| 2011-07-01 to 2011-09-30 | 448,729 | USD | 92 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-07-01 to 2012-09-30 | 52,719 | USD | 92 |
| 2005-05-12 to 2012-09-30 | 878,594 | USD | 2699 |
| 2011-07-01 to 2011-09-30 | 52,719 | USD | 92 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-07-01 to 2012-09-30 | -212,970 | USD | 92 |
| 2005-05-12 to 2012-09-30 | -829,399 | USD | 2699 |
| 2011-07-01 to 2011-09-30 | 452 | USD | 92 |
Inspect the source
- Entity
- NANOVIRICIDES, INC. / CIK 0001379006
- Captured
- 2026-09-20T07:58:03.748Z
- SEC response SHA-256
5d15adcbc42d7ac8bfebbf748da8ae31563dd5d02e790dc3e1b9bde076c805d2
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001379006.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))